Androgenetic Alopecia Market to Reach $7.31 Billion by 2034
Androgenetic alopecia, a genetic condition causing gradual hair loss, affects up to 50% of men and women, with Caucasians showing the highest prevalence. In 2024, Pelage Pharmaceuticals raised $16.75M for hair loss therapies, while a company raised $4M to treat this genetic condition.
Last Updated : 21 April 2026
Category: Therapeutic Area
Insight Code: 5340
Format: PDF / PPT / Excel